SDpress April 2016 May 9, 2016/in Uncategorized /by WuXi AppTec Innovation That Matters Placing ‘Early’ Bets in Biotech – A Chat With Andy Schwab, Co-Founder & Managing Partner, 5AM Ventures Read full article here Next Generation Immuno-Oncology: Creating a New Pathway to ‘Eat’ Cancer – A Chat with Jonathan MacQuitty, CEO, Forty Seven Read full article here How ‘Cool’ Science Translates Into Successful Companies – A Chat with UNITY Biotechnology CEO, Nathaniel David Read full article here Connecting the Global Autism Scientific Community – A Chat With Alan Packer, Senior Scientist, Simons Foundation Autism Research Initiative Read full article here Finding Solutions to Rare Diseases through Genomics: An Interview with Hannes Smárason, WuXi NextCODE Read full article here WuXi News WuXi Biologics Congratulates Ambrx and ZMC for Successful Dosing of a Novel Antibody-Drug Conjugate in Australia Read full article here WuXi Acquires Crelux Read full article here Juno Therapeutics and WuXi Start New Company to Develop Novel Cell-Based Cancer Immunotherapies in China Read full article here WuXi Lab Testing Division’s Analytical and Stability Testing Facilities Passed FDA Inspection Read full article here WuXi Opens Office in South Korea Read full article here Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufactured Biologics in EU Clinical Trial Read full article here World’s Largest Autism Dataset Goes Online Read full article here WuXi NextCODE Becomes the First and Only CAP, CLIA, and California Accredited Sequencing Laboratory in China Read full article here Webinar: Tackling #1 Drug Development Problem: Solubility (May 5) Register to webinar here Huawei and WuXi Join Forces to Create China Precision Medicine Cloud Platform Read full article here WuXi’s STA Subsidiary Opens New Campus in Changzhou Read full article here In This Issue Innovation That Matters WuXi News Industry Beats FDA Updates Upcoming Events Industry Beats Top 10 San Diego Deals in Q1 (Source: Xconomy) Sanford Burnham and GlaxoSmithKline Create New Center for Translational Neuroscience (Source: Sanford Burnham)Salk Scientists Find “Secret Sauce” for Personalized, Functional Insulin-producing Cells (Source: Salk) Study Links Coffee Consumption to Decreased Risk of Colorectal Cancer (Source: USC) ‘Wellderly’ Have More Gene Variants for Good Cognition, Study Finds (Source: The SD Union-Tribune) For Young People with Schizophrenia, Physical and Mental Exercises Offer Hope, UCLA Researchers Find (Source: UCLA) Illumina Invests in New Venture Fund, Will Commit $100M over 10 Years (Source: Illumina) Human Longevity Announces 10 Year Deal with AstraZeneca to Sequence and Analyze Patient Samples from AstraZeneca Clinical Trials (Source: Human Longevity) Acutus Medical Completes $75M Series C Financing (Source: Acutus Medical) Zavante Therapeutics Closes $45M Series A Financing in Support of U.S. Development for a First-in-class Injectable Antibiotic (Source: Zavante) Human Longevity Completes $220M Series B Financing (Source: Human Longevity) EnsoData Raises $550K to Develop Software That Analyzes Sleep Data (Source: Xconomy) RiverVest Venture Partners Opens San Diego Office That’s Been 10 Years in the Making (Source: RiverVest) UCSD Scientist Named to Panel Advising Biden on Cancer ‘Moonshot’ (Source: UCSD) Drug Approvals and Designations FDA Approves Boehringer Ingelheim’s Gilotrif as New Oral Treatment Option for Patients with Squamous Cell Carinoma of the Lung (Source: Boehringer Ingelheim) FDA Approves World’s Smallest Pacemaker for U.S. Patients (Source: Medtronic) FDA Approves Descovy, Gilead’s Third TAF-Based HIV Therapy (Source: Gilead) Upcoming Events April 28, 2016 LA BioMed’s 2016 Innovation Showcase LA BioMed, Torrance April 29, 2016 Ancient DNA and Human Evolution Salk Institute, La Jolla May 2, 2016 Biocom Charity Golf Tournament Biocom, San Diego May 17, 2016 OCTANe’s Technology Investor Forum OCTANe, Orange Country May 25, 2016 Biocom Big Data Executive Summit Biocom, San Diego
